VivoSeq
Gastroenterology

Perianal Crohn's Disease

1

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Perianal Crohn's Disease is an early-stage landscape with 1 program across 1 company. The most active players are S.L.A. Pharma AG.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

29/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

S.L.A. Pharma AG

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Metronidazole

DePuy Orthopaedics

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

7

clinical trials

Completed3 · 43%
Terminated2 · 29%
Unknown status1 · 14%
Active, not recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)
Active, not recruiting·GGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives·Phase 4·NCT04496063·33 enrolled
Stem Cell Fistula Plug in Perianal Crohn's Disease
Completed·WWilliam A. Faubion, M.D.·Phase 1·NCT01915927·20 enrolled
Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease
Completed·SS.L.A. Pharma AG·Phase 1·NCT00774969·19 enrolled
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
Completed·SS.L.A. Pharma AG·Phase 3·NCT00509639·74 enrolled
Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.
Terminated·SSheba Medical Center·N/A·NCT00252369
A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
Terminated·BBraintree Laboratories·Phase 2·NCT01442363·4 enrolled
The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease
Unknown status·SSixth Affiliated Hospital, Sun Yat-sen University·Phase 2/3·NCT03056664·3 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)